This work is licensed under the Creative Commons Attribution 4.0 International License.
Rodriguez-Galindo C, Liu T, Krasin MJ, Wu J, Billups CA, Daw NC, Spunt SL, Rao BN, Santana VM, Navid F. Analysis of prognostic factors in Ewing sarcoma family of tumors: review of St. Jude Children’s Research Hospital studies. Cancer 2007 Jul 15;110(2):375-384.Rodriguez-GalindoCLiuTKrasinMJWuJBillupsCADawNCSpuntSLRaoBNSantanaVMNavidF.Analysis of prognostic factors in Ewing sarcoma family of tumors: review of St2007Jul 15110237538410.1002/cncr.2282117569105Search in Google Scholar
Rodriguez-Galindo C, Billups CA, Kun LE, Kun LE, Rao BN, Merchant TE, Santana VM, Pappo AS. Survival after recurrence of Ewing tumors. Cancer 2002;94(2):561-569.Rodriguez-GalindoCBillupsCAKunLEKunLERaoBNMerchantTESantanaVMPappoASSurvival after recurrence of Ewing tumors200294256156910.1002/cncr.1019211900241Search in Google Scholar
Raciborska A, Bilska K, Drabko K, Chaber R, Sobol G, Pogorzała M, Wyrobek E, Połczyńska K, Rogowska E, Rodriguez-Galindo C, Woźniak W. Validation of a multimodal treatment protocol for Ewing sarcoma – a report from the Polish Pediatric Oncology Group. Pediatr Blood Cancer. 2014 Dec;61(12):2170-2174.RaciborskaABilskaKDrabkoKChaberRSobolGPogorzałaMWyrobekEPołczyńskaKRogowskaERodriguez-GalindoCWoźniakWValidation of a multimodal treatment protocol for Ewing sarcoma – a report from the Polish Pediatric Oncology Group2014Dec61122170217410.1002/pbc.2516725163763Search in Google Scholar
Ladenstein R, Ötscher U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, van den Berg H, Dirksen U, Hjorth L, Michon J, Lewis I, Craft A, Jürgens H. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.J Clin Oncol. 2010;28:3284-3291.LadensteinRÖtscherULeDeley MCWhelanJPaulussenMOberlinOvanden Berg HDirksenUHjorthLMichonJLewisICraftAJürgensHPrimary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial2010283284329110.1200/JCO.2009.22.986420547982Search in Google Scholar
Shankar AG, Ashley S, Craft AW, Pinkerton CR. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. Med Pediatr Oncol. 2003;40:141-147.ShankarAGAshleySCraftAWPinkertonCROutcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma20034014114710.1002/mpo.1024812518341Search in Google Scholar
Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter L, Gebhardt M, Grier HE; Children’s Oncology Group. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2008;51:334-338.LeaveyPJMascarenhasLMarinaNChenZKrailoMMiserJBrownKTarbellNBernsteinMLGranowetterLGebhardtMGrierHE; Children’s Oncology Group.Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the Children’s Oncology Group20085133433810.1002/pbc.21618272835718506764Search in Google Scholar
Stahl M, Ranft A, Paulussen M, Bölling T, Vieth V, Bielack S, Görtitz I, Braun-Munzinger G, Hardes J, Jürgens H, Dirksen U. Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Pediatr Blood Cancer 2011;57:549-553.StahlMRanftAPaulussenMBöllingT,ViethVBielackSGörtitzI,Braun-MunzingerGHardesJJürgensH,DirksenURisk of recurrence and survival after relapse in patients with Ewing sarcoma20115754955310.1002/pbc.2304021442722Search in Google Scholar
Rodriguez-Galindo C. Ewing sarcoma and its many faces: are we close to a cure? Med Wieku Rozwoj. 2013 Apr-Jun;17(2):113-116.Rodriguez-GalindoC.Ewing sarcoma and its many faces: are we close to a cure?2013Apr-Jun172113116Search in Google Scholar
Klingebiel T, Boos J, Beske F, Hallmen E, Int-Veen C, Dantonello T, Treuner J, Gadner H, Marky I, Kazanowska B, Koscielniak E. Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer. 2008 Apr;50(4):739-745.KlingebielTBoosJBeskeFHallmenEInt-VeenCDantonelloTTreunerJGadnerHMarkyIKazanowskaBKoscielniakETreatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial2008Apr50473974510.1002/pbc.2149418286501Search in Google Scholar
Blomqvist C, Wiklund T, Pajunen M, Virolainen M, Elomaa I. Oral trofosfamide: an active drug in the treatment of soft-tissue sarcoma. Cancer Chemother. Pharmacol. (1995) 36: 263. doi:10.1007/BF00685858.BlomqvistCWiklundTPajunenMVirolainenMElomaaIOral trofosfamide: an active drug in the treatment of soft-tissue sarcoma. Cancer Chemother19953626310.1007/BF006858587781149Open DOISearch in Google Scholar
Kroiss M, Deutschbein T, Schlötelburg W, Ronchi CL, Neu B, Müller HH, Quinkler M, Hahner S, Heidemeier A, Fassnacht M; German Adrenocortical Carcinoma Study Group. Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide. Horm Cancer. 2016 Jun;7(3):211-218.KroissMDeutschbeinTSchlötelburgWRonchiCLNeuBMüllerHH,QuinklerMHahnerSHeidemeierAFassnachtMGerman Adrenocortical Carcinoma Study Group. Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide2016Jun7321121810.1007/s12672-016-0260-726961793Search in Google Scholar
Atzpodien J, Morawek L, Fluck M, Reitz M. Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients. Cancer Chemother Pharmacol. 2009 Oct;64(5):901-905.AtzpodienJMorawekLFluckMReitzMBleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients2009Oct64590190510.1007/s00280-009-0939-319229537Search in Google Scholar
Greiner J, Küfer R, Reske SN, Martin V, Döhner H, Ringhoffer M. Metronomic treatment with low-dose trofosfamide leads to a long-term remission in a patient with docetaxel-refractory advanced metastatic prostate cancer. Case Rep Med. 2010:2010:395720. doi: 10.1155/2010/395720.GreinerJKüferR,ReskeSNMartinVDöhnerH,RinghofferMMetronomic treatment with low-dose trofosfamide leads to a long-term remission in a patient with docetaxel-refractory advanced metastatic prostate cancer2010201039572010.1155/2010/395720285385720396674Open DOISearch in Google Scholar
Jahnke K, Thiel E, Bechrakis NE, Willerding G, Kraemer DF, Fischer L, Korfel A. Ifosfamide or trofosfamide in patients with intraocular lymphoma. J Neurooncol. 2009 Jun;93(2):213-217.JahnkeKThielEBechrakisNEWillerdingGKraemerDFFischerLKorfelAIfosfamide or trofosfamide in patients with intraocular lymphoma2009Jun93221321710.1007/s11060-008-9761-819099202Search in Google Scholar
Hartmann JT, Oechsle K, Mayer F, Kanz L, Bokemeyer C. Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas. Anticancer Res. 2003 Mar-Apr;23(2C):1899-1901.HartmannJTOechsleKMayerFKanzLBokemeyerCPhase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas2003Mar-Apr232C18991901Search in Google Scholar
Laws HJ, van Kaick B, Pape H, Paulussen M, Göbel U. Relapse after high-dose therapy in relapsed Ewing’s tumor patients: effects of maintenance chemotherapy in two selected patients? Onkologie 2003 Dec;26(6):573-577.LawsHJvanKaick BPapeHPaulussenMGöbelURelapse after high-dose therapy in relapsed Ewing’s tumor patients: effects of maintenance chemotherapy in two selected patients?2003Dec26657357710.1159/00007415414709933Search in Google Scholar
Kollmannsberger C, Brugger W, Hartmann JT, Maurer F, Böhm P, Kanz L, Bokemeyer C. Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma. Anticancer Drug 1999 Jun;10(5):453-456.KollmannsbergerCBruggerWHartmannJTMaurerFBöhmP,KanzLBokemeyerCPhase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma1999Jun10545345610.1097/00001813-199906000-0000410477164Search in Google Scholar
Jurgens C, Weston C, Lewis I et al. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer 2006;47(l):22-29.JurgensCWestonCLewisIet alSafety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G200647l222910.1002/pbc.2082016572419Search in Google Scholar
Cash T, Mcllvaine E, Rrailo MD, Lessnick SL, Lawlor ER, Laack N, Sorger J, Marina N, Grier HE, Granowetter L, Womer RB, DuBois SG. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2016 Oct;63(10):1771-1779.CashTMcllvaineERrailoMDLessnickSLLawlorERLaackNSorgerJMarinaNGrierHEGranowetterLWomerRBDuBoisSGComparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children’s Oncology Group2016Oct63101771177910.1200/jco.2015.33.15_suppl.10051Search in Google Scholar
Gunsilius E, Gierlich T, Mross K, Gastl G, Unger C. Palliative chemotherapy in pretreated patients with advanced cancer: oral trofosfamide is effective in ovarian carcinoma. Cancer Invest. 2001;19(8):808-811.GunsiliusEGierlichTMrossKGastlGUngerCPalliative chemotherapy in pretreated patients with advanced cancer: oral trofosfamide is effective in ovarian carcinoma200119880881110.1081/CNV-10010774211768034Search in Google Scholar
Raciborska A, Bilska K, Rychlowska-Pruszynska M, Drabko K, Chaber R, Pogorzała M, Połczyńska K, Godziński J, Rodriguez-Galindo C, Wożniak W. Internal hemipelvectomy in the management of pelvic Ewing sarcoma – are outcomes better than with radiation therapy? J Pediatr Surg. 2014 0ct;49(10):1500-1504.RaciborskaABilskaKRychlowska-PruszynskaMDrabkoKChaberRPogorzałaMPołczyńskaKGodzińskiJRodriguez-GalindoCWożniakWInternal hemipelvectomy in the management of pelvic Ewing sarcoma – are outcomes better than with radiation therapy?20140ct49101500150410.1016/j.jpedsurg.2014.04.01325280655Search in Google Scholar
Reichardt P, Pink D, Tilgner J, Kretzschmar A, Thuss-Patience PC, Dörken B. Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis. Onkologie 2002 Dec;25(6):541-546.ReichardtPPinkDTilgnerJKretzschmarAThuss-PatiencePCDörkenB.Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas2002Dec25654154610.1159/00006862512566899Search in Google Scholar